Related Experiment Video
Updated: Aug 10, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Low incidence of acute myocardial infarction in beta-thalassaemia trait carriers
T Tassiopoulos1, G Stamatelos, N Zakopoulos
1First Department of Internal Medicine, University of Athens School of Medicine, Laiko General Hospital, Greece.
Insights
Heterozygosity for beta-thalassaemia trait may protect against acute myocardial infarction. This protective effect is linked to lower cholesterol, mild anemia, and reduced blood viscosity in carriers.
Area of Science:
- Cardiology
- Genetics
- Hematology
Background:
- Beta-thalassaemia trait is a common genetic condition.
- Acute myocardial infarction (AMI) is a leading cause of mortality.
- The potential protective role of genetic traits against cardiovascular disease warrants investigation.
Purpose of the Study:
- To investigate the association between beta-thalassaemia trait and acute myocardial infarction.
- To determine if carrying the beta-thalassaemia trait influences AMI incidence.
Main Methods:
- A case-control study comparing AMI patients with fracture patients.
- Estimation of beta-thalassaemia trait frequency in 209 AMI patients and 212 controls.
- Standard clinical and laboratory criteria for diagnosing AMI and beta-thalassaemia trait.
Main Results:
- Lower frequency of beta-thalassaemia trait observed in AMI patients (4.31%) compared to the general Greek population (7.61%).
- The protective association was more pronounced in older age groups.
- No significant difference in beta-thalassaemia trait frequency between control subjects and the general population.
Conclusions:
- Heterozygosity for beta-thalassaemia may confer protection against acute myocardial infarction.
- Potential mechanisms include lower serum cholesterol, mild anemia, and reduced blood viscosity.
- Beta-thalassaemia trait carriers may have a reduced risk of developing AMI.
Abstract:
The frequency of beta-thalassaemia trait was estimated in 209 consecutive patients hospitalized for acute myocardial infarction in order to answer the question of the possible protective effect of heterozygosity for beta-thalassaemia on the incidence of the disease. 212 patients hospitalized during the same period for various accidental bone fractures served as controls. Diagnosis of both, acute myocardial infarction and beta-thalassaemia trait, was based on the standard clinical and laboratory criteria. We found that patients with acute myocardial infarction had low frequency of beta-thalassaemia trait (4.31%), as compared with the mean incidence of heterozygosity for beta-thalassaemia in the whole Greek population (7.61%) (p < 0.02). This finding was more clear in the older age groups of the patients studied. No statistically significant differences were found in the frequency of beta-thalassaemia trait between control subjects (8.49%) and the whole Greek population. We concluded that the heterozygosity for beta-thalassaemia may protect the carrier from acute myocardial infarction. This effect is probably related to low serum cholesterol levels, slight anaemia, and microcytosis lowering the blood viscosity. These changes are usually present in the beta-thalassaemia trait carriers.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Transient Ischemic Attack l: Introduction
